Harrow Health Inc (NASDAQ: HROW) stock suffered a major decline of -36.0% on 11/14/23. The shares closed at $8.21. The stock has been weak relative to the market over the last nine months and has declined -38.7% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, HROW is expected to continue to be a major Value Builder.
Harrow Health has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Harrow Health has a good Appreciation Score of 82 but a very low Power Rating of 8, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment